Can an app supporting psoriasis patients improve adherence to topical treatment? A single-blind randomized controlled trial.

ABSTRACT:

Background

Topical corticosteroid or corticosteroid/calcipotriol preparations are recommended first-line topical treatments of psoriasis, but a main cause for the lack of efficacy of topical treatments is considered low rates of adherence to topical drugs. Patient support by the use of applications (apps) for smartphones is suggested to improve medical adherence.

Methods/design

Design: An investigator-initiated, single-center, single-blind, parallel-group, phase-4 clinical superiority randomized controlled trial (RCT).

Participants

134 patients 18 to 75 years of age with mild-to-moderate psoriasis, who are capable of reading English language, own a smartphone, and are candidates for the study drug calcipotriol and betamethasone dipropionate (Cal/BD) cutaneous foam onc

SUBMITTER: Svendsen MT 

PROVIDER: S-EPMC5804085 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature